Clinical Trials

15 enrolled 13 charts

Leukemia-Lymphoma, Adult T-Cell

NCT06761677 2026-02-05

A Phase 1b/2 Study of Intravenous Brincidofovir in Patients With Relapsed or Refractory Lymphoma and Relapsed or Refractory Extranodal Natural Killer/T-cell Lymphoma

Phase 1/2 Suspended

43 enrolled

Immunoblastic Lymphadenopathy, Lymphoma, Recurrence, Leukemia-Lymphoma, Adult T-Cell, Lymphoma, T-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic, Epstein-Barr Virus Infections, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT06035497 2025-05-14

A Study to Assess the Safety, Tolerability, Efficacy, and Drug Levels of BMS-986369 (Golcadomide) in Participants With Relapsed or Refractory T-cell Lymphomas in Japan (GOLSEEK-3)

Phase 1/2 Recruiting

85 enrolled

Immunoblastic Lymphadenopathy, Lymphoma, Mycosis Fungoides, Recurrence, Leukemia-Lymphoma, Adult T-Cell, Lymphoma, T-Cell, Lymphoma, T-Cell, Peripheral, Lymphoma, Large-Cell, Anaplastic, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Lymphoma, Extranodal NK-T-Cell

NCT06909474 2025-04-03

Clinical Trial of CD5-targeted CAR-NK Therapy for Relapse/Refractory T-Cell Hematologic Malignancies

Phase 1 Recruiting

15 enrolled

Phase 1 Active not recruiting

Leukemia-Lymphoma, Adult T-Cell, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT02732275 2025-02-07

DS-3201b in Participants With Lymphomas

100 enrolled

Phase 2 Active not recruiting

Lymphoma, Lymphoma, Non-Hodgkin, Leukemia-Lymphoma, Adult T-Cell, Lymphoma, B-Cell, Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral

NCT03678883 2024-11-07

9-ING-41 in Patients with Advanced Cancers

350 enrolled

BreastCNSGastrointestinalGenitourinaryLymphoidOther hematologic neoplasmSarcomaThoracic

Bone Neoplasms, Breast Neoplasms, Glioma, Kidney Neoplasms, Lung Neoplasms, Lymphoma, Non-Hodgkin, Neoplasm Metastasis, Neoplasms, Hereditary Sensory and Autonomic Neuropathies, Pancreatic Neoplasms, Sarcoma, Colorectal Neoplasms, Leukemia-Lymphoma, Adult T-Cell

NCT04014374 2024-07-24

Post-authorization Safety Study of Allogeneic Hematopoietic Stem Cell Transplantation in Patients Treated With Mogamulizumab

Recruiting

150 enrolled

Leukemia, Lymphoma, Leukemia-Lymphoma, Adult T-Cell, Lymphoma, T-Cell, Cutaneous

NCT01626664 2024-04-25

KW-0761 or Investigator's Choice in Subjects With Previously Treated Adult T-cell Leukemia-Lymphoma (ATL)

71 enrolled 15 charts

Leukemia-Lymphoma, Adult T-Cell, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT00924170 2023-11-14

Phase II Trial of LMB-2, Fludarabine and Cyclophosphamide for Adult T-Cell Leukemia

Phase 1/2 Completed

18 enrolled 30 charts

Leukemia, Leukemia-Lymphoma, Adult T-Cell

NCT01712659 2023-01-10

Ruxolitinib for Adult T-Cell Leukemia

Phase 1/2 Terminated

19 enrolled 17 charts

Leukemia, T-Cell, Leukemia-Lymphoma, Adult T-Cell

NCT02689453 2022-04-29

Subcutaneous Recombinant Human IL-15 (s.c. rhIL-15) and Alemtuzumab for People With Refractory or Relapsed Chronic and Acute Adult T-cell Leukemia (ATL)

Phase 1 Completed

11 enrolled 16 charts

Leukemia-Lymphoma, Adult T-Cell, Leukemia, Prolymphocytic, T-Cell, Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral

NCT02580552 2020-11-23

Safety, Tolerability and Pharmacokinetics of MRG-106 in Patients With Mycosis Fungoides (MF), CLL, DLBCL or ATLL

Phase 1 Completed

66 enrolled

Mycosis Fungoides, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia-Lymphoma, Adult T-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT00117845 2019-11-19

Phase II Study of the Efficacy and Toxicity of Ontak(Registered Trademark) (Denileukin Diftitox) in the Therapy of Adult T-Cell Leukemia

Phase 2 Terminated

17 enrolled 9 charts

Lymphoproliferative Disorders, Leukemia-Lymphoma, Adult T-Cell

NCT03226119 2018-09-13

MP Diagnostics HTLV Blot 2.4 Post-Market Clinical Study

Phase 4 Completed

150 enrolled

Leukemia-Lymphoma, Adult T-Cell, HTLV-I Infections, HTLV-II Infections, Paraparesis, Tropical Spastic

NCT01724177 2018-05-29

A Phase 2 Study of Lenalidomide in Patients With Relapsed or Recurrent Adult T-cell Leukemia-lymphoma

26 enrolled 15 charts

Leukemia-Lymphoma, Adult T-Cell

NCT03146013 2017-06-12

Dual Algorithm Post Market Clinical Study

Completed

100 enrolled

Leukemia-Lymphoma, Adult T-Cell, HTLV-I Infections, HTLV-II Infections, Paraparesis, Tropical Spastic

NCT01173887 2017-03-30

Multicenter, Randomized, Open-label, Parallel-group Study to Compare mLSG15 + KW-0761 to mLSG15

44 enrolled

Leukemia-Lymphoma, Adult T-Cell

NCT00920790 2017-03-29

Phase II Study of KW-0761 in Subjects With CCR4-positive Adult T-cell Leukemia-lymphoma

28 enrolled 10 charts

Leukemia-Lymphoma, Adult T-Cell

NCT01000285 2017-03-28

ATLL

Phase 1/2 Completed

18 enrolled 13 charts

Leukemia-Lymphoma, Adult T-Cell

NCT00145002 2016-09-22

A Study for Aggressive Adult T-cell Leukemia-lymphoma (ATLL)

Phase 3 Completed

130 enrolled

Lymphoma, Leukemia-Lymphoma, Adult T-Cell

NCT01274533 2016-05-23

Lenalidomide in HTLV-1 Adult T-Cell Leukemia

4 enrolled 2 charts

Leukemia-Lymphoma, Adult T-Cell, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT00699296 2012-11-27

Study of Oral LBH589 in Patients With Cutaneous T-cell Lymphoma and Adult T-cell Leukemia/Lymphoma

Phase 2 Terminated

4 enrolled

Leukemia-Lymphoma, Adult T-Cell, Lymphoma, T-Cell, Cutaneous

NCT00061048 2012-10-31

Campath-1H for Treating Adult T-Cell Leukemia/Lymphoma

29 enrolled 11 charts

Leukemia-Lymphoma, Adult T-Cell

NCT00355472 2012-10-18

Phase I Study of KW-0761 in Relapsed Patients With CCR4-Positive ATL and PTCL

Phase 1 Completed

16 enrolled 12 charts

Leukemia-Lymphoma, Adult T-Cell, Lymphoma, T-Cell, Peripheral

NCT01467024 2011-11-08

Evaluation of the MP Diagnostics HTLV Blot 2.4

Unknown

600 enrolled